Genotyping Market
授權報價
| Single User License | $4,500 USD |
| Multiple User License | $5,500 USD |
| Custom Research License | $8,000 USD |
完整報告名稱與涵蓋範圍
Genotyping Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Instruments, Reagents & Kits, Software and Services), By Technology (PCR, Capillary Electrophoresis, Microarrays, Sequencing, Mass Spectrometry, Others), By Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural Biotechnology, Animal Genetics, Others), By End Use (Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research Laboratories, Academic Institutes, Others), By Region & Competition, 2021-2031F
報告摘要
Market Overview
The Global Genotyping Market is projected for substantial growth, expanding from USD 16.72 Billion in 2025 to USD 27.86 Billion by 2031, at an 8.88% CAGR. This market expansion is primarily driven by the increasing prevalence of chronic genetic diseases and the crucial role of genomic analysis in both pharmacogenomics and the development of targeted therapies. The growing reliance on genetic insights for disease management is evidenced by projections such as the American Cancer Society's estimate of approximately 2,041,910 new cancer cases in the United States alone in 2025, highlighting a critical global demand for precision oncology and genetic profiling technologies. Despite this strong growth, the market faces significant challenges, particularly concerning data privacy and security. The necessity to adhere to stringent and often varied regional regulatory standards for handling vast amounts of sensitive genetic information creates considerable operational complexities and liability risks for diagnostic providers and research institutions, thereby impeding the seamless exchange of genomic data vital for large-scale research and broader clinical implementation of genotyping services.
Market Driver
The genotyping market is primarily propelled by two key factors: significant cost reductions in DNA sequencing and genomic analysis, and the expanding applications of precision medicine and pharmacogenomics. Substantial decreases in sequencing costs, driven by maturing high-throughput technologies, have democratized access to genetic data, enabling laboratories to process vast sample volumes that were previously cost-prohibitive. This economic shift fuels the scalability of population-health studies and commercial diagnostics, as demonstrated by Illumina's Q1 2025 report showing over 30 percent year-over-year increase in sequencing gigabase output and UK Biobank's release of comprehensive metabolomics data for 500,000 participants. Concurrently, the growth of precision medicine and pharmacogenomics is fundamentally reshaping therapeutic development; pharmaceutical companies and clinicians increasingly use genotypic data to identify biomarkers, predicting drug efficacy and toxicity to optimize treatment outcomes. This transition to targeted regimens is heavily supported by regulatory trends, with the Personalized Medicine Coalition reporting that 38 percent of new FDA-approved therapeutic molecular entities in 2024 were personalized medicines, underscoring the central role of genetic profiling in modern drug discovery and approval.
Market Challenge
Data privacy and security represent a critical challenge significantly hindering the Global Genotyping Market's growth. The industry's reliance on aggregating massive datasets of sensitive genetic profiles for pharmacogenomics and precision medicine makes it highly vulnerable to cyber threats. The imperative to comply with rigorous and often fragmented regulatory standards across various jurisdictions creates substantial operational bottlenecks, diverting resources from innovation and complicating the cross-border sharing of genomic data essential for biomarker validation and large-scale research. The inherent liability risks associated with maintaining these data pools prompt stakeholders to restrict access, directly stalling clinical implementation. The severity of this vulnerability is illustrated by the American Hospital Association's report that cyberattacks and data breaches within the healthcare sector impacted a record 259 million individuals in the United States in 2024, leading to eroded patient trust and the establishment of restrictive data silos that impede seamless information exchange vital for market expansion.
Market Trends
Two pivotal trends are shaping the genotyping market: the integration of Artificial Intelligence (AI) for genotypic data interpretation and the increasing application in agricultural biotechnology and animal breeding. AI integration is addressing analytical bottlenecks caused by exponential genomic dataset growth, with the market shifting towards AI-driven platforms that automate complex variant classification and clinical reporting, moving beyond manual bioinformatics. This demand for computational efficiency is evident in Tempus AI Inc.'s Q3 2024 report, showing a 64.4 percent year-over-year acceleration in its AI-enabled data platform's revenue to $64.5 million, highlighting the industry's growing reliance on intelligent algorithms for actionable precision medicine insights. Simultaneously, genotyping's expanded application in agricultural biotechnology and animal breeding broadens its scope beyond human healthcare, utilizing genomic selection tools to enhance food security and livestock productivity. Agribusinesses are extensively adopting these tools to identify desirable traits like disease resistance and feed efficiency, optimizing breeding programs and reducing operational risks, a resilience demonstrated by Neogen Corporation's Annual Report 2024, which noted an 8 percent increase in its Genomics Services revenue, underscoring genotyping's critical role in modernizing agricultural supply chains and ensuring sustainable production standards.
Key Market Players
* Thermo Fisher Scientific Inc.
* Illumina Inc.
* QIAGEN N.V.
* F Hoffmann-La Roche AG
* Danaher Corporation
* Agilent Technologies, Inc.
* Eurofins Scientific Inc.
* General Electric Compnay
* Bio-Rad Laboratories Inc.
* Standard BioTools Inc.
Report Scope
In this report, the Global Genotyping Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
# Genotyping Market, By Product
* Instruments
* Reagents & Kits
* Software
* Services
# Genotyping Market, By Technology
* PCR
* Capillary Electrophoresis
* Microarrays
* Sequencing
* Mass Spectrometry
* Others
# Genotyping Market, By Application
* Pharmacogenomics
* Diagnostics and Personalized Medicine
* Agricultural Biotechnology
* Animal Genetics
* Others
# Genotyping Market, By End Use
* Pharmaceutical and Biopharmaceutical Companies
* Diagnostics and Research Laboratories
* Academic Institutes
* Others
# Genotyping Market, By Region
* North America
United States
Canada
Mexico
* Europe
France
United Kingdom
Italy
Germany
Spain
* Asia Pacific
China
India
Japan
Australia
South Korea
* South America
Brazil
Argentina
Colombia
* Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Genotyping Market.
Available Customizations:
Global Genotyping Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
* Detailed analysis and profiling of additional market players (up to five).
目錄 Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Genotyping Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Instruments, Reagents & Kits, Software, Services)
5.2.2. By Technology (PCR, Capillary Electrophoresis, Microarrays, Sequencing, Mass Spectrometry, Others)
5.2.3. By Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural Biotechnology, Animal Genetics, Others)
5.2.4. By End Use (Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research Laboratories, Academic Institutes, Others)
5.2.5. By Region
5.2.6. By Company (2025)
5.3. Market Map
6. North America Genotyping Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Technology
6.2.3. By Application
6.2.4. By End Use
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Genotyping Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Technology
6.3.1.2.3. By Application
6.3.1.2.4. By End Use
6.3.2. Canada Genotyping Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Technology
6.3.2.2.3. By Application
6.3.2.2.4. By End Use
6.3.3. Mexico Genotyping Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Technology
6.3.3.2.3. By Application
6.3.3.2.4. By End Use
7. Europe Genotyping Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Technology
7.2.3. By Application
7.2.4. By End Use
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Genotyping Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Technology
7.3.1.2.3. By Application
7.3.1.2.4. By End Use
7.3.2. France Genotyping Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Technology
7.3.2.2.3. By Application
7.3.2.2.4. By End Use
7.3.3. United Kingdom Genotyping Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Technology
7.3.3.2.3. By Application
7.3.3.2.4. By End Use
7.3.4. Italy Genotyping Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Technology
7.3.4.2.3. By Application
7.3.4.2.4. By End Use
7.3.5. Spain Genotyping Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Technology
7.3.5.2.3. By Application
7.3.5.2.4. By End Use
8. Asia Pacific Genotyping Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Technology
8.2.3. By Application
8.2.4. By End Use
8.2.5. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Genotyping Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Technology
8.3.1.2.3. By Application
8.3.1.2.4. By End Use
8.3.2. India Genotyping Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Technology
8.3.2.2.3. By Application
8.3.2.2.4. By End Use
8.3.3. Japan Genotyping Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Technology
8.3.3.2.3. By Application
8.3.3.2.4. By End Use
8.3.4. South Korea Genotyping Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Technology
8.3.4.2.3. By Application
8.3.4.2.4. By End Use
8.3.5. Australia Genotyping Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Technology
8.3.5.2.3. By Application
8.3.5.2.4. By End Use
9. Middle East & Africa Genotyping Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Technology
9.2.3. By Application
9.2.4. By End Use
9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Genotyping Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Technology
9.3.1.2.3. By Application
9.3.1.2.4. By End Use
9.3.2. UAE Genotyping Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Technology
9.3.2.2.3. By Application
9.3.2.2.4. By End Use
9.3.3. South Africa Genotyping Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Technology
9.3.3.2.3. By Application
9.3.3.2.4. By End Use
10. South America Genotyping Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Technology
10.2.3. By Application
10.2.4. By End Use
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Genotyping Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Technology
10.3.1.2.3. By Application
10.3.1.2.4. By End Use
10.3.2. Colombia Genotyping Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Technology
10.3.2.2.3. By Application
10.3.2.2.4. By End Use
10.3.3. Argentina Genotyping Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Technology
10.3.3.2.3. By Application
10.3.3.2.4. By End Use
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Genotyping Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Thermo Fisher Scientific Inc.
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Illumina Inc.
15.3. QIAGEN N.V.
15.4. F Hoffmann-La Roche AG
15.5. Danaher Corporation
15.6. Agilent Technologies, Inc.
15.7. Eurofins Scientific Inc.
15.8. General Electric Compnay
15.9. Bio-Rad Laboratories Inc.
15.10. Standard BioTools Inc.
16. Strategic Recommendations
17. About Us & Disclaimer
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 TechSci Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們